New immunosupressants in the treatment of thyroid-associated ophthalmopathy
10.3760/cma.j.issn.1000-6699.2013.11.020
- VernacularTitle:新型免疫抑制剂应用于甲状腺相关性眼病的治疗
- Author:
Wanshu ZENG
;
Wei REN
- Publication Type:Journal Article
- Keywords:
Thyroid-associated ophthalmopathy;
New immunosupressant;
Treatment
- From:
Chinese Journal of Endocrinology and Metabolism
2013;29(11):995-997
- CountryChina
- Language:Chinese
-
Abstract:
Thyroid-associated ophthalmopathy (TAO) is an inflammatory eye disease associated with thyroid autoimmune disorder.The traditional treatments have yielded limited efficacy but with some side effects.Recently,researches have shown that some new immunosupressants may be used for the treatment of TAO with significantly improved symptoms,and reduction in clinical activity score.